Results 201 to 210 of about 10,004,929 (375)

Commemorating the Publication of Volume 30 of the Japanese Journal of Clinical Oncology: Where are We Heading? [PDF]

, 2000
Kaoru Abe
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study

, 1991
P J Thompson, Peter Wilson, Richard H. Osborne, Mark Slevin, F Wiltshaw, Peter Blake, Peter Harper, Robert E. Coleman, Christopher Williams, John Sweetenham, Anna-Mary Young, Robert Leonard   +11 more
openalex   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303 [PDF]

, 2001
Yasuaki Yamada, Masao Tomonaga, Haruhiko Fukuda, Shuichi Hanada, Atae Utsunomiya, Mitsutoshi Tara, Masayuki Sano, Shu‐ichi Ikeda, Kiyoshi Takatsuki, Mitsuo Kozuru, Koichi Araki, Fumio Kawano, Miyuki Niimi, Kensei Tobinai, Tomomitsu Hotta, M Shimoyama, Other Members Of The Lymphoma Study Group of The Japan Clini   +16 more
openalex   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology group

, 1991
James D. Cox, N. Azarnia, Roger W. Byhardt, K.H. Shin, Bahman Emami, Carlos A. Perez   +5 more
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Digital twins: a new paradigm in oncology in the era of big data

ESMO Real World Data and Digital Oncology
Recent advancements in health care digitalization opened the collection and availability of big data, whose analysis requires artificial intelligence-based technologies to facilitate the development of predictive tools supporting decision making in ...
L. Mollica, C. Leli, F. Sottotetti, S. Quaglini, L.D. Locati, S. Marceglia   +5 more
doaj  

Large language model trained on clinical oncology data predicts cancer progression. [PDF]

NPJ Digit Med
Zhu M, Lin H, Jiang J, Jinia AJ, Jee J, Pichotta K, Waters M, Rose D, Schultz N, Chalise S, Valleru L, Morin O, Moran J, Deasy JO, Pilai S, Nichols C, Riely G, Braunstein LZ, Li A.   +18 more
europepmc   +1 more source